{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:29:58Z","timestamp":1762522198360},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gastrohep.2018.06.013","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T21:36:17Z","timestamp":1534023377000},"page":"629-635","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Experiencia en pr\u00e1ctica cl\u00ednica de optimizaci\u00f3n de tiopurinas mediante determinaci\u00f3n de sus metabolitos en la enfermedad inflamatoria intestinal"],"prefix":"10.1016","volume":"41","author":[{"given":"Eugenia","family":"S\u00e1nchez Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"R\u00edos Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mesonero Gismero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Albillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lopez-Sanroman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2018.06.013_bib0145","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","article-title":"The efficacy of azathioprine for the treatment of inflammatory bowel disease: A 30 year review","volume":"50","author":"Fraser","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.gastrohep.2017.11.007","article-title":"Recomendaciones GETECCU sobre el uso de tiopurinas en la EII. Revisi\u00f3n de las principales indicaciones, as\u00ed como aspectos pr\u00e1cticos de seguridad, eficacia y modo de empleo","volume":"41","author":"Bermejo","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0155","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1046\/j.1365-2036.2002.01385.x","article-title":"Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis","volume":"16","author":"Domenech","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0160","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000067.pub3","article-title":"Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease","author":"Chande","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","article-title":"Clinical pharmacology and pharmacogenetics of thiopurines","volume":"64","author":"Sahasranaman","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0170","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.4049\/jimmunol.170.10.4986","article-title":"Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides","volume":"170","author":"Quemeneur","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MIB.0000000000000197","article-title":"Update 2014: Advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD","volume":"21","author":"Amin","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0180","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/apt.12555","article-title":"Randomised clinical trial: Individualised vs. weight-based dosing of azathioprine in Crohn's disease","volume":"39","author":"Dassopoulos","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0190","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2036.2011.04756.x","article-title":"Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients","volume":"34","author":"Gonz\u00e1lez-Lama","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0195","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/j.gastro.2006.01.046","article-title":"Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis","volume":"130","author":"Osterman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0200","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/1744666X.2017.1351298","article-title":"Optimising use of thiopurines in inflammatory bowel disease","volume":"13","author":"Dart","year":"2017","journal-title":"Exp Rev Clin Immunol"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0205","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/flgastro-2015-100681","article-title":"Monitoring thiopurine metabolites in inflammatory bowel disease","volume":"7","author":"Gonz\u00e1lez-Lama","year":"2016","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/MCG.0000000000000889","article-title":"Higuer thioguanine nucleotide metabolite levels are associated with better long-term outcomes in patients with Inflammatory Bowel disease","volume":"52","author":"Yarur","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0215","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1572-0241.2008.01848.x","article-title":"Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: A review","volume":"103","author":"Gisbert","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0220","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ecco-jcc\/jjw130","article-title":"Early assessment of thiopurine metabolites identifies patients at risk of thiopurine-induced leukopenia in inflammatory bowel disease","volume":"11","author":"Wong","year":"2017","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0225","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/apt.13879","article-title":"Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease","volume":"45","author":"Wong","year":"2017","journal-title":"Alimentary Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0230","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.dld.2004.09.029","article-title":"Thiopurines in inflammatory bowel disease: Pharmacogenetics, therapeutic drug monitoring and clinical recommendations","volume":"37","author":"Al Hadithy","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0235","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0245","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/FTD.0000000000000455","article-title":"Analytical pitfalls of therapeutic drug monitoring of thiopurines in patients with inflammatory bowel disease","volume":"39","author":"Simsek","year":"2017","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0250","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/ecco-jcc\/jjx149","article-title":"A role for thiopurine metabolites in the synergism between thiopurines and infliximab in inflammatory bowel disease","volume":"12","author":"Mogensen","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0255","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4321\/S1130-01082005000400005","article-title":"Adherence to treatment in inflammatory bowel disease","volume":"97","author":"L\u00f3pez San Rom\u00e1n","year":"2005","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0260","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.crohns.2010.04.003","article-title":"Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence","volume":"4","author":"Stocco","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0265","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ibd.23021","article-title":"Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease","volume":"19","author":"Hoentjen","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0270","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/MIB.0000000000001131","article-title":"Azathioprine with allopurinol: Lower deoxythioguanosine in DNA and transcriptome changes indicate mechanistic differences to azathioprine alone","volume":"23","author":"Coulthard","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0275","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2036.2007.03365.x","article-title":"Adherence to thiopurine treatment in out-patients with Crohn's disease","volume":"26","author":"Bokemeyer","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2018.06.013_bib0280","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn's disease (CALM): A multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2018","journal-title":"Lancet"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057051830205X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057051830205X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T16:50:38Z","timestamp":1604767838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021057051830205X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S021057051830205X"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2018.06.013","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experiencia en pr\u00e1ctica cl\u00ednica de optimizaci\u00f3n de tiopurinas mediante determinaci\u00f3n de sus metabolitos en la enfermedad inflamatoria intestinal","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2018.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}